The Latest News

Stay up-to-date on the latest news, ongoing insights and event information plus access a detailed archive of past events and press releases from ITS including details on collaboration and partnerships with the world’s leading pharmaceutical companies to identify specific target classes and therapeutic indications.

August 24, 2020

Tentarix Biotherapeutics Launches with a $50 Million Series A Financing

Read More

November 5, 2019

Innovative Targeting Solutions and Former Amgen Executive Team up to Launch A2 Biotherapeutics with a $57 Million Series A

Read More

October 21, 2019

Innovative Targeting Solutions Inc. announces the issuance of two European patents applying the HuTARG™ platform to targeted mutagenesis and the engineering of functional agonists to GPCRs

Read More